Photo of Paul Crowe
  • Room 0B.022 - CEM

    United Kingdom

20042012

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paul Crowe is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Research Output

Restoration of adipose function in obese, glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein β upregulation

McGinty, A., Powell, L., Crowe, P., Kankara, C., McPeake, J., McCance, D., Young, I. & Trimble, E., Aug 2012, In : Clinical Science. 123, 3, p. 135–146 12 p.

Research output: Contribution to journalArticle

Open Access
File
  • 10 Citations (Scopus)
    380 Downloads (Pure)

    Synthesis of A83586C analogs with potent anticancer and beta-catenin/ TCF4/osteopontin inhibitory effects and insights into how A83586C modulates E2Fs and pRb.

    Hale, K. J., Manaviazar, S., Lazarides, L., George, J., Walters, M. A., Cai, J., Delisser, V. M., Bhatia, G. S., Peak, S. A., Dalby, S. M., Lefranc, A., Chen, Y. P., Wood, A. W., Crowe, P., Erwin, P. & El-Tanani, M., 05 Feb 2009, In : Organic Letters. 11, 3, p. 737-740 4 p.

    Research output: Contribution to journalArticle

  • 10 Citations (Scopus)

    Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation

    Mason, C. K., McFarlane, S., Johnston, P., Crowe, P., Erwin, P. J., Domostoj, M. M., Campbell, F., Manaviazar, S., Hale, K. J. & El-Tanani, M., 01 Mar 2008, In : Molecular Cancer Therapeutics. 7, 3, p. 548-558 11 p.

    Research output: Contribution to journalArticle

  • 63 Citations (Scopus)